Cargando…
Is karyotyping still needed in the diagnosis and monitoring of chronic myeloid leukemia?
Autor principal: | Chauffaille, Maria de Lourdes L.F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568583/ https://www.ncbi.nlm.nih.gov/pubmed/28830611 http://dx.doi.org/10.1016/j.bjhh.2016.12.003 |
Ejemplares similares
-
When karyotype is decisive for myelodysplastic syndromes diagnosis
por: Perazzio, Aline dos Santos Borgo, et al.
Publicado: (2019) -
Identifying the similarities and differences between single nucleotide polymorphism array (SNPa) analysis and karyotyping in acute myeloid leukemia and myelodysplastic syndromes
por: Noronha, Thiago Rodrigo de, et al.
Publicado: (2015) -
Chromosomal aberrations detected by Fluorescence in situ hybridization in 344 Brazilian chronic lymphocytic leukemia patients
por: Zorovich, Maria Eduarda Sanseverino de Lourenço da Motta, et al.
Publicado: (2017) -
Sole Infrequent Karyotypic Aberration Trisomy 6 in a Patient with Acute Myeloid Leukemia and Breast Cancer in Remission
por: Aydın, Mürüvvet Seda, et al.
Publicado: (2017) -
Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival
por: Tefferi, Ayalew, et al.
Publicado: (2022)